0      0

2022 ISPE Annual Meeting & Expo

SES207c - 2022 FOYA Winner: CRISPR Therapeutics, Future-Proofing for a New Era of Medicine

Nov 1, 2022 1:45pm ‐ Nov 1, 2022 3:15pm


Category: Innovation
CRISPR Therapeutics at the time this project started was an early clinical stage biopharmaceutical company with multiple product candidates. The challenge was to design a manufacturing facility that allows for simultaneous production, testing and release of multiple clinical grade drug product candidates at different scales and stages of development, maintain product segregation to conform with regulatory requirements, and conduct rapid changeovers between different product campaigns all with an eye towards eventually transitioning successful candidates to commercial launch.


  • Brad Ebel, Executive Director, Facilities and Engineering, CRISPR Therapeutics

You must be logged in and own this session in order to post comments.